What is the appropriate evaluation and management for a 5-year-old girl presenting with fever and a maculopapular rash involving the legs and the soles of her feet?

Evaluation and Management of 5-Year-Old with Fever and Maculopapular Rash on Legs and Soles

This presentation requires immediate consideration of Rocky Mountain Spotted Fever (RMSF) as the primary diagnosis, with empiric doxycycline treatment initiated without waiting for confirmatory testing, while simultaneously evaluating for Kawasaki disease and other life-threatening causes.

Critical Initial Assessment

The combination of fever and rash involving the soles of the feet in a 5-year-old creates a narrow but critical differential that includes two potentially fatal conditions requiring immediate action:

Primary Concern: Rocky Mountain Spotted Fever

RMSF must be treated empirically based on clinical suspicion alone 1. The CDC guidelines explicitly present a case nearly identical to this scenario: a 5-year-old girl with fever and maculopapular rash on legs including soles 1. The key teaching point is that treatment should never be delayed waiting for serologic confirmation, as serology results take 3+ days and are often negative early in disease 1.

Immediate actions for RMSF consideration:

• Query about tick exposure (though absence of tick bite history does NOT exclude RMSF—most patients don't recall a bite) 1
• Determine timing: when did rash appear relative to fever onset?
• Geographic location and season (spring/summer months increase suspicion)
• Check for outdoor activities in the past 2 weeks

Laboratory evaluation:

• CBC with differential (expect normal WBC, thrombocytopenia develops as disease progresses) 1
• Comprehensive metabolic panel
• Blood culture
• Obtain acute serum for Rickettsia rickettsii antibodies (IgG and IgM), but do not wait for results 1

Treatment decision: If clinical suspicion exists based on geography, season, and presentation, initiate doxycycline 2.2 mg/kg orally twice daily immediately 1. The guidelines are unequivocal that doxycycline is appropriate even in young children when RMSF is suspected, as the mortality risk of untreated RMSF far outweighs any theoretical dental staining concerns.

Secondary Concern: Kawasaki Disease

Kawasaki disease must be simultaneously evaluated, as it shares the feature of rash involving extremities and can cause coronary artery aneurysms if untreated 2, 3.

Diagnostic criteria require fever ≥5 days PLUS 4 of 5 principal features 2, 3:

1. Bilateral non-purulent conjunctival injection
2. Oral changes (cracked lips, strawberry tongue, oral erythema)
3. Polymorphous rash
4. Extremity changes (erythema/edema of hands/feet, or later periungual desquamation)
5. Cervical lymphadenopathy ≥1.5 cm

Critical nuances:

• If fever has been present <5 days but clinical features are compelling, experienced clinicians can diagnose earlier 2, 3
• Diagnosis can be made with only 3 clinical features if coronary artery abnormalities are seen on echocardiography 2, 3
• Features may not all be present simultaneously—careful history is essential 2, 3

If Kawasaki disease is suspected:

• Obtain CRP and ESR (should be elevated) 2
• If inflammatory markers elevated: check albumin, transaminases, CBC, urinalysis 2
• Obtain echocardiography urgently to assess for coronary artery involvement 2
• Treatment: IVIG 2 g/kg as single infusion PLUS high-dose aspirin 80-100 mg/kg/day divided into 4 doses 2

Algorithmic Approach

Step 1: Assess for life-threatening causes requiring immediate treatment

• Appearance: toxic, ill-appearing, hemodynamically unstable? → Consider meningococcemia, toxic shock syndrome
• Petechiae or purpura present? → Blood culture, empiric antibiotics immediately
• Geographic/seasonal risk for RMSF? → Empiric doxycycline

Step 2: Characterize the rash precisely

• Distribution: Started where? Spread how? Involves palms/soles?
• Morphology: Truly maculopapular vs petechial vs desquamating?
• Timing: Appeared before, with, or after fever?

Step 3: Count Kawasaki criteria

• Duration of fever (must be ≥5 days for classic diagnosis)
• Presence of conjunctival injection (bilateral, non-purulent)
• Oral changes
• Extremity changes (acute erythema/edema OR subacute desquamation)
• Lymphadenopathy
• If ≥4 criteria present → Obtain echo and inflammatory markers urgently

Step 4: Consider other diagnoses

• Viral exanthems (enterovirus, EBV, measles in unvaccinated) 3
• Scarlet fever (sandpaper-like rash, strawberry tongue, pharyngitis)
• Drug reaction (recent medication exposure?)
• Staphylococcal/streptococcal toxin-mediated disease 3

Critical Pitfalls to Avoid

1. Waiting for serologic confirmation before treating RMSF - This is the most common fatal error. RMSF mortality is 20-30% untreated but <5% with early doxycycline 1.

2. Dismissing RMSF because no tick bite recalled - Most RMSF patients don't remember a tick bite 1.

3. Requiring full 5 days of fever before diagnosing Kawasaki disease - If clinical features are compelling, diagnosis and treatment can begin earlier 2, 3.

4. Missing incomplete Kawasaki disease - Patients with fewer than 4 criteria but prolonged fever and elevated inflammatory markers need echocardiography 2.

5. Assuming benign viral exanthem without excluding dangerous causes - The presence of sole involvement is unusual for common viral illnesses and should heighten concern.

Disposition

• If RMSF suspected: Start doxycycline, close follow-up in 24-48 hours to assess clinical response
• If Kawasaki disease diagnosed: Hospital admission for IVIG infusion and cardiology consultation
• If neither diagnosis clear but child appears well: Close outpatient follow-up with clear return precautions for worsening symptoms, development of additional Kawasaki criteria, or lack of improvement

The key principle is that both RMSF and Kawasaki disease have significant mortality/morbidity if untreated, but excellent outcomes with early appropriate therapy. When in doubt, err on the side of treatment rather than observation.